ClinicalTrials.gg
RecruitingNCT05576350TRAC-ERUpdated Mar 30, 2025

TRAC-ER Intervention to Reduce Risky Alcohol Use and HIV Risk

An interventional study of Smartphone Based Alcohol Monitoring (SAM) and Tracking and Reducing Alcohol Consumption (TRAC) in Risk Behavior, Alcohol Use Disorder and HIV Infections, sponsored by University of Kentucky. Recruiting at 2 sites in United States. Open to participants aged 18 Years to 35 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-03-30.

Sponsored by University of Kentucky · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Started Dec 2024; still recruiting 1 year 11 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
405
Allocation
Randomized
Ages
18 Years to 35 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 84 studies in Risk-Taking with a site in United States — 9 open to participants now, 11 under way, none of them phase 3. Risk-Taking · United States.

Planned enrollment
25th of 77
405 · median 237
Started
2024
with 5 others
No phase
60 of 84
7 open now
Primary completion
2027-05
later than 3 of 10 live
Registered
75th of 84
by date

Among the 84 studies in Risk-Taking with a site in United States, this one is the 25th largest by planned enrollment of the 77 interventional ones that give a count, is one of 6 that started in 2024, is one of 60 with no phase, reaches primary completion later than 3 of the 10 other live ones, and was the 75th registered.

Risk-Taking

136 studies on the registry are indexed under Risk-Taking; 18 are open to participants now.

Browse Risk-Taking studies →

Open to participants now

9 of the 84 studies in Risk-Taking with a site in United States are open now. Recruiting first, the newest first:

3 more — sign in →

All 9 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 15 Risk-Taking studies recruiting now, 4 (27%) set no upper age limit and 11 (73%) stop at 75 or younger; 8 take children under 18; 9 take healthy volunteers.

This study: 18 Years to 35 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 84 studies in Risk-Taking with a site in United States, or all of them as a file.
02

Study summary

Ecological momentary interventions (EMI), which use phones to deliver messages to reduce alcohol use and related risk behaviors during or prior to drinking events, can help to address triggers in real-time. GPS tracking can determine when individuals visit places they have previously reported drinking or triggers to drink and then EMI messages can be delivered upon arrival to prevent risky alcohol use. A mobile app has been developed that uses GPS tracking to determine when individuals visit "risky" places and then delivers a survey asking what behaviors they engaged in while at the location.

The goal of the proposed study is to use this app to enhance the Tracking and Reducing Alcohol Consumption (TRAC) intervention by delivering messages that encourage participants to employ strategies discussed during TRAC sessions when arriving at risky places. When they leave these places, they will complete a survey and breathalyzer reading in order to collect event-level self-report and biological data on alcohol use and HIV risk. If their breathalyzer result indicates alcohol use, they will receive harm reduction messaging. It is expected that combining TRAC with EMI ("TRAC-ER") will increase effectiveness by reinforcing topics discussed during these sessions, providing in-the-moment messaging to address triggers, and collecting real-time alcohol use data.

Read the detailed description

For this study, the investigators will enhance an existing mHealth intervention (TRAC) to reduce alcohol use among young adults at risk for HIV by combining the intervention with an app which delivers EMI messages in real-time. Upon enrollment, participants will be randomized into one of 3 arms: TRAC-ER (EMI messaging, TRAC intervention, and smartphone-based alcohol monitoring), TRAC (TRAC intervention and smartphone-based alcohol monitoring), or a comparison group (smartphone-based alcohol monitoring only).

Participants will be recruited from Kentucky and Connecticut through community-based recruitment and health clinics.

Preliminary data used for this study were collected from a study (PI: Lauckner, K01AA02530) testing the TRAC intervention with people living with HIV/AIDS, which has shown promising preliminary results, with high feasibility, acceptability, and encouraging preliminary outcomes.

03

Conditions studied

  • Risk Behavior
  • Alcohol Use Disorder
  • HIV Infections

Keywords

  • motivational interviewing
  • behavior
  • ecological momentary intervention
  • EMI
  • TRAC
  • mobile
  • GPS
04

Who can participate

Ages eligible
18 Years to 35 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • is between the ages of 18-35 at the start of the study
  • owns a smartphone
  • has not been diagnosed with
  • screens positively for at-risk alcohol use (score of 4 or higher on the AUDIT-C, OR report engaging in binge drinking at least once over the past 12 months).
  • meets criteria for pre-exposure prophylaxis (PrEP) OR is identified as being at high risk for HIV (i.e., reports history of using PrEP/PEP, reports unprotected sex, etc.)

Exclusion criteria

Exclusion Criteria:

  • do not speak English
  • are actively detoxifying from substances and need medical supervision
  • a score of 20 or greater on the Alcohol Use Disorders Identification Test
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

HIV

The human immunodeficiency virus, which weakens the immune system.

Many studies now accept people whose HIV is controlled on treatment, judged by the viral load and the CD4 count. Check the limits this study sets.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
405 participants (estimated)

Study arms

  • Experimental
    SAM-Only Comparison Group

    Participants in this group will engage only in smartphone-based alcohol monitoring.

    Behavioral: Smartphone Based Alcohol Monitoring (SAM)

  • Experimental
    TRAC plus SAM

    Participants in this group will receive the Tracking and Reducing Alcohol Consumption (TRAC) intervention and smartphone-based alcohol monitoring.

    Behavioral: Smartphone Based Alcohol Monitoring (SAM) · Behavioral: Tracking and Reducing Alcohol Consumption (TRAC)

  • Experimental
    TRAC-ER plus SAM

    Participants in this group will receive the Tracking and Reducing Alcohol Consumption (TRAC) intervention combined with GPS-based ecological momentary interventions (EMI) and smartphone-based alcohol monitoring.

    Behavioral: Smartphone Based Alcohol Monitoring (SAM) · Behavioral: Tracking and Reducing Alcohol Consumption (TRAC) · Behavioral: TRAC-ER

Interventions

  • BehavioralSmartphone Based Alcohol Monitoring (SAM)

    Smartphone-based alcohol monitoring (SAM) using mobile breathalyzers and surveys.

  • BehavioralTracking and Reducing Alcohol Consumption (TRAC)

    The TRAC intervention focuses on increasing motivation and building skills for avoiding triggers and managing situations that encourage drinking. It requires four 30-minute sessions with a counselor using videoconferencing and mobile phones. In addition to receiving the four sessions of intervention content, participants will complete smartphone-based self-monitoring of alcohol consumption, which will be discussed during intervention sessions.

  • BehavioralTRAC-ER

    Ecological momentary interventions (EMI) use phones to deliver messages to reduce alcohol use and related risk behaviors during or prior to drinking events. GPS tracking can determine when individuals visit places they have previously reported drinking or triggers to drink and then EMI messages can be delivered upon arrival to prevent risky alcohol use.

06

What researchers measure

Primary outcomes

  1. Number of drinking days

    Number of days in which alcohol was consumed based on breathalyzer readings greater than 0.00

    Time frame: Measured daily for 30 day periods during months 1, 2, 3, 6, and 9

Secondary outcomes

  1. Number of binge drinking episodes

    Number of binge drinking episodes (occasions when participants had 5+ drinks based on self-reported number of drinks)

    Time frame: Measured daily for 30 day periods during months 1, 2, 3, 6, and 9

  2. Number of drinks/drinking day

    3 items: alcohol consumed (yes or no), number of drinks, and time spent drinking

    Time frame: Measured daily for 30 day periods during months 1, 2, 3, 6, and 9

07

Study locations

2 of 2 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Dec 2024 (actual). Primary completion is estimated for May 2027, 29 months after the start.

Of 65 non-industry interventional studies with no phase under Risk-Taking, half reached primary completion within 28 months of starting (the median), counting those still running; a quarter within 9 and three quarters within 48. This study's planned 29 months is close to that.

Counting every sponsor, half of 68 studies reached it within 28 months; a quarter within 7 and three quarters within 49.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 29, 2022
First posted
Oct 12, 2022
StartActual
Dec 9, 2024
Primary completionEst.
May 2027
CompletionEst.
May 2027
Last update
Mar 30, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Mar 30, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05576350
Lead sponsor
University of Kentucky
Responsible party
Carolyn Lauckner (Associate Professor, University of Kentucky) — Principal investigator
First posted
Oct 12, 2022
Start date
Dec 9, 2024
Primary completion
May 2027 (estimated)
Completion
May 2027 (estimated)
Last update
Mar 30, 2025

Study contacts

Carolyn Lauckner, PhD
Contact
carolyn.lauckner@uky.edu
859-562-3335
Carolyn Lauckner, PhD
principal investigator · University of Kentucky
Trace Kershaw, PhD
principal investigator · Yale University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion